Clinical Profile and Outcomes of Paraquat Poisoning: A One-Year Case Series from a Tertiary Care Hospital in Northeast India
International Journal of Current Pharmaceutical Review and Research · 31.05.2026 · 18 (05)
DOI: 10.25258/ijcpr.18.5.226 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.05.2026. Verfasst von Tarliboyina Rama Krishna und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Paraquat poisoning remains a significant cause of morbidity and mortality in developing countries, with no specific antidote and limited therapeutic options. The toxic effects of paraquat primarily result from oxidative stress, leading to multi-organ failure involving the lungs, liver, and kidneys. This study aimed to evaluate the clinical spectrum, management strategies, and predictors of outcome among patients with paraquat poisoning in a tertiary care hospital. Methodology: This prospective observational study was conducted over six months in the Department of Medicine at a tertiary care center in India. Fifty patients with confirmed paraquat ingestion were enrolled after applying inclusion and exclusion criteria. Demographic, clinical, and laboratory data were recorded at admission. All patients received supportive management, including immunosuppressive therapy with methylprednisolone and cyclophosphamide, along with antioxidants and organ-specific supportive care. Outcomes were assessed as survival or death. Data were analyzed using SPSS version 26.0, and statistical significance was determined with chi-square and t-tests.
Results
The mean age of patients was 31 years, with a male predominance (68%). Most cases (90%) resulted from intentional ingestion, and 60% presented within six hours of exposure. The mortality rate was 46%. Renal impairment (91% vs 26%), hepatic dysfunction (74% vs 22%), pulmonary involvement (57% vs 18%), multi organ failure (61% vs 7%), and delayed hospital presentation (>6 h) were significantly associated with mortality (p < 0.05). Despite aggressive therapy, including immunosuppressive and supportive measures, outcomes remained poor in severe cases.
Conclusion
Paraquat poisoning continues to have a high fatality rate due to irreversible multi-organ dysfunction. Early presentation, prompt supportive therapy, and intensive care are crucial for improving survival. Larger multicentric studies are warranted to develop standardized treatment and prognostic models.
Zitieren
APA
Krishna, T. R., Das, M. P., Patoa, A., Sarkar, H., Dey, S., Talukdar, B., & Roy, R. K. (2026). Clinical Profile and Outcomes of Paraquat Poisoning: A One-Year Case Series from a Tertiary Care Hospital in Northeast India. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.226
Vancouver
Krishna TR, Das MP, Patoa A, Sarkar H, Dey S, Talukdar B, et al. Clinical Profile and Outcomes of Paraquat Poisoning: A One-Year Case Series from a Tertiary Care Hospital in Northeast India. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.226
BibTeX
@article{Krishna2026,
author = {Krishna, Tarliboyina Rama and Das, Madhumita P. and Patoa, Ankita and Sarkar, Heerakjyoti and Dey, Soumik and Talukdar, Bhupali and Roy, Rajib Kumar},
title = {Clinical Profile and Outcomes of Paraquat Poisoning: A One-Year Case Series from a Tertiary Care Hospital in Northeast India},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {05},
doi = {10.25258/ijcpr.18.5.226}
}
EUVIMED